MEDP Medpace
- 398.275
- +9.005+2.31%
Medpace News
Here's How Much You Would Have Made Owning Medpace Hldgs Stock In The Last 5 Years
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 35.09% on an annualized basis producing an average annual return of 48.03%. Currently, Medpace Hldgs has a market capit
Zacks.com Featured Highlights Medpace, American Axle, Diebold Nixdorf, Euronet and Omnicom
5 Stocks With Upgraded Broker Ratings Worth Investing in Now
Medpace(MEDP.US) 10% Shareholder Sells US$3.31 Million in Common Stock
$Medpace(MEDP.US)$ 10% Shareholder Troendle August J. sold 8,268 shares of common stock on May 8, 9, 2024 at an average price of $400.41 for a total value of $3.31 million.Source: Announcement What is
Medpace Holdings (MEDP) Rose as It Reported Strong Matrices
Investment management company Vulcan Value Partners recently released its first quarter 2024 investor letter.
(MEDP) - Analyzing Medpace Hldgs's Short Interest
Medpace Hldgs's (NYSE:MEDP) short percent of float has risen 3.92% since its last report.
Medpace(MEDP.US) 10% Shareholder Sells US$21.13 Million in Common Stock
$Medpace(MEDP.US)$ 10% Shareholder Troendle August J. sold 52,404 shares of common stock on May 6, 7, 2024 at an average price of $403.2 for a total value of $21.13 million.Source: Announcement What i
Medpace Holdings Insider Sold Shares Worth $21,129,347, According to a Recent SEC Filing
August J. Troendle, 10% Owner, Director, CEO, on May 06, 2024, sold 52,404 shares in Medpace Holdings (MEDP) for $21,129,347. Following the Form 4 filing with the SEC, Troendle has control over a tota
Have Medpace Holdings Insiders Been Selling Stock?
We wouldn't blame Medpace Holdings, Inc. (NASDAQ:MEDP) shareholders if they were a little worried about the fact that August Troendle, the Chairman & CEO recently netted about US$6.8m selling shares a
Medpace(MEDP.US) 10% Shareholder Sells US$6.55 Million in Common Stock
$Medpace(MEDP.US)$ 10% Shareholder Troendle August J. sold 16,330 shares of common stock on May 1, 2, 2024 at an average price of $401.33 for a total value of $6.55 million.Source: Announcement What i
Medpace Holdings Insider Sold Shares Worth $6,553,671, According to a Recent SEC Filing
August J. Troendle, 10% Owner, Director, CEO, on May 01, 2024, sold 16,330 shares in Medpace Holdings (MEDP) for $6,553,671. Following the Form 4 filing with the SEC, Troendle has control over a total
$100 Invested In Medpace Hldgs 5 Years Ago Would Be Worth This Much Today
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 35.08% on an annualized basis producing an average annual return of 47.25%. Currently, Medpace Hldgs has a market capit
Medpace(MEDP.US) 10% Shareholder Sells US$6.78 Million in Common Stock
$Medpace(MEDP.US)$ 10% Shareholder Troendle August J. sold 16,930 shares of common stock on Apr 29, 30, 2024 at an average price of $400.65 for a total value of $6.78 million.Source: Announcement What
Medpace Holdings Insider Sold Shares Worth $6,782,987, According to a Recent SEC Filing
August J. Troendle, 10% Owner, Director, CEO, on April 29, 2024, sold 16,930 shares in Medpace Holdings (MEDP) for $6,782,987. Following the Form 4 filing with the SEC, Troendle has control over a tot
Form 144 | Medpace(MEDP.US) Insider Proposes to Sell 76.13 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 29, $Medpace(MEDP.US)$ Insider August J. Troendle intends to sell 190K shares of its common stock on Apr 29, with a total market value of approximately $76.13 million. Au
Guggenheim: Maintains Medpace Hldgs (MEDP.US) rating, adjusted from buy to buy rating, and adjusted target price from $453.00 to $464.00.
Guggenheim: Maintains Medpace Hldgs (MEDP.US) rating, adjusted from buy to buy rating, and adjusted target price from $453.00 to $464.00.
Guggenheim Maintains Buy on Medpace Hldgs, Raises Price Target to $464
Guggenheim analyst Sandy Draper maintains Medpace Hldgs with a Buy and raises the price target from $453 to $464.
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2024 Earnings Call Transcript
Medpace Holdings, Inc. Just Beat EPS By 30%: Here's What Analysts Think Will Happen Next
Baird Maintains Outperform on Medpace Hldgs, Raises Price Target to $454
Baird analyst Eric Coldwell maintains Medpace Hldgs with a Outperform and raises the price target from $446 to $454.
Analysis
Price Target
No Data
